BANK OF MONTREAL /CAN/ - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 80 filers reported holding UROGEN PHARMA LTD in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2021$10,000
-84.6%
534
-82.6%
0.00%
Q4 2020$65,000
+182.6%
3,062
+168.8%
0.00%
Q3 2020$23,000
-45.2%
1,139
-35.2%
0.00%
Q2 2020$42,000
+740.0%
1,758
+459.9%
0.00%
Q1 2020$5,000
-93.9%
314
-87.2%
0.00%
Q4 2019$82,000
+78.3%
2,459
+27.0%
0.00%
Q3 2019$46,000
-17.9%
1,936
+23.8%
0.00%
Q2 2019$56,0001,5640.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 1,111,050$9,099,0004.23%
GREAT POINT PARTNERS LLC 873,424$7,153,0001.72%
Wildcat Capital Management, LLC 533,139$4,366,0001.45%
Opaleye Management Inc. 238,670$1,955,0000.88%
MENORA MIVTACHIM HOLDINGS LTD. 2,949,489$24,156,0000.44%
Annandale Capital, LLC 84,331$691,0000.27%
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. 25,330$206,0000.18%
RTW INVESTMENTS, LP 857,464$7,023,0000.18%
Harel Insurance Investments & Financial Services Ltd. 1,025,611$8,400,0000.18%
BENDER ROBERT & ASSOCIATES 41,131$337,0000.13%
View complete list of UROGEN PHARMA LTD shareholders